Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4510 results

Sort By:

Brain Activity During Bladder Filling: Pilot Study of an fMRI Protocol

Study ID: NCT05255692
Start Date: 2025-05-01
End Date: 2026-09-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

6

Intervention / Treatment

invasive urodynamic evaluation

functional magnetic resonance imaging during bladder filling

Sponsor

University Hospital, Ghent

Source: clinicaltrials.gov

Share:
Add to list

VR and Scrip Training of PWA, Randomized Controlled Trial

Study ID: NCT06722092
Start Date: 2025-06
End Date: 2028-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

105

Intervention / Treatment

VR-based script training

Conventional script training

Sponsor

The Hong Kong Polytechnic University

Source: clinicaltrials.gov

Share:
Add to list

Neurocognitive Function Changes with Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

Study ID: NCT06751992
Start Date: 2025-05-01
End Date: 2027-10-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

92

Intervention / Treatment

Conversion to extended-release tacrolimus

Maintenance of immediate-release tacrolimus

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

IO Vancomycin Spine

Study ID: NCT06748144
Start Date: 2025-04
End Date: 2030-04
Study Type

Interventional

Study Phase

Phase3

No. of Participants

30

Intervention / Treatment

Intraosseous Vancomycin

Intravenous Vancomycin

Sponsor

The Methodist Hospital Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Tegoprazan and Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment

Study ID: NCT06894992
Start Date: 2025-04-07
End Date: 2025-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

162

Intervention / Treatment

Tegoprazan

Lansoprazole

Sponsor

Mario Steffanus

Source: clinicaltrials.gov

Share:
Add to list

The Diagnostic Application of PSMAPET/MR in Patients Undergoing Secondary Prostate Puncture

Study ID: NCT06901492
Start Date: 2025-06-01
End Date: 2028-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Prostate biopsy guided by PSMA PET/CT

Prostate biopsy guided by mpMRI/US

Systematic prostate biopsy

Sponsor

Nanjing First Hospital, Nanjing Medical University

Source: clinicaltrials.gov

Share:
Add to list

Reimagining Interventions for Support and Education in Hypersensitivity Pneumonitis

Study ID: NCT06811389
Start Date: 2025-04
End Date: 2026-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Re-imagining Interventions for Support and Education in Hypersensitivity Pneumonitis (RISE-HP)

Staying Well

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

Patiromer and Diet/hrQoL in Chronic Dialysis

Study ID: NCT06858280
Start Date: 2025-06-15
End Date: 2026-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

40

Intervention / Treatment

Patiromer 8400 Mug [Well

Placebo

Sponsor

Mario Negri Institute for Pharmacological Research

Source: clinicaltrials.gov

Share:
Add to list

Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM

Study ID: NCT06468462
Start Date: 2025-05-01
End Date: 2028-07-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

2900

Intervention / Treatment

WHO-recommended periodic presumptive treatment

Doxycycline post-exposure prophylaxis

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

Paclitaxel Lipid Suspension for Patients with Platinum-Resistant /Refractory Ovarian Cancer

Study ID: NCT06867562
Start Date: 2025-04
End Date: 2026-03
Study Type

Interventional

Study Phase

Phase3

No. of Participants

166

Intervention / Treatment

Paclitaxel Lipid Suspension

Conventional paclitaxel or Taxol

Sponsor

Jina Pharmaceuticals Inc.

Source: clinicaltrials.gov

Share:
Add to list